Goldman Sachs’s BioAtla BCAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-30,343
| Closed | -$17.9K | – | 5072 |
|
|
2024
Q4 | $17.9K | Buy |
+30,343
| New | +$17.9K | ﹤0.01% | 4917 |
|
|
2024
Q3 | – | Sell |
-358,920
| Closed | -$492K | – | 4833 |
|
|
2024
Q2 | $492K | Buy |
358,920
+311,736
| +661% | +$427K | ﹤0.01% | 3966 |
|
|
2024
Q1 | $162K | Buy |
47,184
+8,433
| +22% | +$29K | ﹤0.01% | 4381 |
|
|
2023
Q4 | $95.3K | Sell |
38,751
-10,382
| -21% | -$25.5K | ﹤0.01% | 4468 |
|
|
2023
Q3 | $83.5K | Sell |
49,133
-33,086
| -40% | -$56.2K | ﹤0.01% | 4419 |
|
|
2023
Q2 | $247K | Buy |
82,219
+25,480
| +45% | +$76.4K | ﹤0.01% | 4322 |
|
|
2023
Q1 | $152K | Sell |
56,739
-36,311
| -39% | -$97.3K | ﹤0.01% | 4594 |
|
|
2022
Q4 | $768K | Sell |
93,050
-12,246
| -12% | -$101K | ﹤0.01% | 3841 |
|
|
2022
Q3 | $811K | Buy |
105,296
+27,968
| +36% | +$215K | ﹤0.01% | 3956 |
|
|
2022
Q2 | $220K | Sell |
77,328
-108,086
| -58% | -$308K | ﹤0.01% | 4859 |
|
|
2022
Q1 | $927K | Buy |
185,414
+132,235
| +249% | +$661K | ﹤0.01% | 4160 |
|
|
2021
Q4 | $1.04M | Buy |
53,179
+6,470
| +14% | +$127K | ﹤0.01% | 3989 |
|
|
2021
Q3 | $1.38M | Buy |
46,709
+35,270
| +308% | +$1.04M | ﹤0.01% | 3761 |
|
|
2021
Q2 | $485K | Sell |
11,439
-8,399
| -42% | -$356K | ﹤0.01% | 4456 |
|
|
2021
Q1 | $1.01M | Sell |
19,838
-85,162
| -81% | -$4.33M | ﹤0.01% | 3897 |
|
|
2020
Q4 | $3.57M | Buy |
+105,000
| New | +$3.57M | ﹤0.01% | 2688 |
|